POSEIDA THERAPEUTICS
PSTX Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-01-08
2025-01-08
MYLET JOHANNA
Chief Financial Officer
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-576K
$0.00
8
$925.92M
2025-01-08
2025-01-08
AMADO RAFAEL
D - Sale to Issuer
Stock Option (Right to Buy)
-82,550
$0.00
2
$925.92M
2025-01-08
2025-01-08
BAUM CHARLES
D - Sale to Issuer
Stock Option (Right to Buy)
-112K
$0.00
3
$925.92M
2025-01-08
2025-01-08
COLLINS CYNTHIA
D - Sale to Issuer
Stock Option (Right to Buy)
-171K
$0.00
4
$925.92M
2025-01-08
2025-01-08
CORNING LUKE
D - Sale to Issuer
Stock Option (Right to Buy)
-129K
$0.00
4
$925.92M
2025-01-08
2025-01-08
GERGEN MARK
President and CEO
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-1.76M
$0.00
7
$925.92M
2025-01-08
2025-01-08
LEONHARDT HARRY
GC & Chief Compliance Officer
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-607K
$0.00
5
$925.92M
2025-01-08
2025-01-08
LLOYD MARCEA BLAND
D - Sale to Issuer
Stock Option (Right to Buy)
-197K
$0.00
8
$925.92M
2025-01-08
2025-01-08
RIZVI SYED ALI-AAMIR
Chief Medical Officer
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-250K
$0.00
1
$925.92M
2025-01-08
2025-01-08
YAREMA KRISTIN
President and CEO
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-844K
$0.00
2
$925.92M
2025-01-08
2025-01-08
LEONHARDT HARRY
GC & Chief Compliance Officer
U - Disposition
Common Stock
-224K
1
$925.92M
2025-01-08
2025-01-08
MYLET JOHANNA
Chief Financial Officer
U - Disposition
Common Stock
-255K
1
$925.92M
2025-01-08
2025-01-08
RIZVI SYED ALI-AAMIR
Chief Medical Officer
U - Disposition
Common Stock
-185K
1
$925.92M
2024-12-10
2024-12-11
GERGEN MARK
Executive Chairman
M - Exercise
Employee Stock Option (Right to Buy)
-30,000
$0.00
1
$925.92M
2024-12-10
2024-12-11
GERGEN MARK
Executive Chairman
M - Exercise
Common Stock
30,000
$3.00
90,000
1
$925.92M
2024-11-26
2024-11-27
GERGEN MARK
Executive Chairman
M - Exercise
Common Stock
30,000
$3.00
90,000
1
$925.92M
2024-11-26
2024-11-27
GERGEN MARK
Executive Chairman
M - Exercise
Employee Stock Option (Right to Buy)
-30,000
$0.00
1
$925.92M
2024-04-01
2024-04-03
RIZVI SYED ALI-AAMIR
Chief Medical Officer
A - Grant
Employee Stock Option (Right to Buy)
250K
$0.00
1
$925.92M
2024-04-01
2024-04-03
RIZVI SYED ALI-AAMIR
Chief Medical Officer
A - Grant
Common Stock
185K
$0.00
1
$925.92M
2024-03-01
2024-03-04
LEONHARDT HARRY
GC & Chief Compliance Officer
F - Tax
Common Stock
-16,306
$4.00
-65,224
1
$925.92M
2024-03-01
2024-03-04
MYLET JOHANNA
Chief Financial Officer
F - Tax
Common Stock
-18,091
$4.00
-72,364
1
$925.92M
2024-03-01
2024-03-04
WARNER BRENT
President, Gene Therapy
F - Tax
Common Stock
-35,739
$4.00
-143K
1
$925.92M
2024-03-01
2024-03-04
LEONHARDT HARRY
GC & Chief Compliance Officer
A - Grant
Employee Stock Option (Right to Buy)
112K
$0.00
1
$925.92M
2024-03-01
2024-03-04
LEONHARDT HARRY
GC & Chief Compliance Officer
A - Grant
Common Stock
80,743
$0.00
1
$925.92M
2024-03-01
2024-03-04
MYLET JOHANNA
Chief Financial Officer
A - Grant
Employee Stock Option (Right to Buy)
112K
$0.00
1
$925.92M
2024-03-01
2024-03-04
MYLET JOHANNA
Chief Financial Officer
A - Grant
Common Stock
80,743
$0.00
1
$925.92M
2024-03-01
2024-03-04
WARNER BRENT
President, Gene Therapy
A - Grant
Employee Stock Option (Right to Buy)
112K
$0.00
1
$925.92M
2024-03-01
2024-03-04
WARNER BRENT
President, Gene Therapy
A - Grant
Common Stock
80,743
$0.00
1
$925.92M
2024-01-02
2024-01-04
GERGEN MARK
Executive Chairman
A - Grant
Stock Option (Right to buy)
173K
$0.00
1
$925.92M
2024-01-02
2024-01-04
YAREMA KRISTIN
President and CEO
A - Grant
Stock Option (Right to buy)
345K
$0.00
1
$925.92M
2023-04-11
2023-04-12
YAREMA KRISTIN
President, Cell Therapy
A - Grant
Employee Stock Option (Right to Buy)
498K
$0.00
1
$925.92M
2023-04-11
2023-04-12
YAREMA KRISTIN
President, Cell Therapy
A - Grant
Common Stock
357K
$0.00
1
$925.92M
2023-03-01
2023-03-02
GERGEN MARK
President and CEO
A - Grant
Employee Stock Option (Right to Buy)
364K
$0.00
1
$925.92M
2023-03-01
2023-03-02
LEONHARDT HARRY
GC & Chief Compliance Officer
A - Grant
Employee Stock Option (Right to Buy)
125K
$0.00
1
$925.92M
2023-03-01
2023-03-02
LEONHARDT HARRY
GC & Chief Compliance Officer
A - Grant
Common Stock
92,772
$0.00
1
$925.92M
2023-03-01
2023-03-02
MYLET JOHANNA
Chief Financial Officer
A - Grant
Employee Stock Option (Right to Buy)
125K
$0.00
1
$925.92M
2023-03-01
2023-03-02
MYLET JOHANNA
Chief Financial Officer
A - Grant
Common Stock
92,772
$0.00
1
$925.92M
2023-03-01
2023-03-02
WARNER BRENT
President, Gene Therapy
A - Grant
Stock Option (Right to Buy)
125K
$0.00
1
$925.92M
2023-03-01
2023-03-02
WARNER BRENT
President, Gene Therapy
A - Grant
Common Stock
92,772
$0.00
1
$925.92M
2023-03-01
2023-03-02
LEONHARDT HARRY
GC & Chief Compliance Officer
F - Tax
Common Stock
-4,323
$5.00
-21,615
1
$925.92M
2023-03-01
2023-03-02
MYLET JOHANNA
Chief Financial Officer
F - Tax
Common Stock
-4,323
$5.00
-21,615
1
$925.92M
2023-03-01
2023-03-02
WARNER BRENT
President, Gene Therapy
F - Tax
Common Stock
-26,617
$5.00
-133K
1
$925.92M
2022-08-08
2022-08-10
OSTERTAG ERIC
Executive Chairman
P - Purchase
Common Stock
143K
$4.00
571K
1
$925.92M
2022-08-08
2022-08-10
MALIN LIFE SCIENCES HOLDINGS LTD
P - Purchase
COMMON STOCK
2.15M
$4.00
8.60M
1
$925.92M
2022-03-16
2022-03-18
INGALLS KERRY
Chief Operating Officer
P - Purchase
Common Stock
3,000
$4.00
12,000
1
$925.92M
2022-03-01
2022-03-01
INGALLS KERRY
Chief Operating Officer
A - Grant
Common Stock
50,000
$0.00
1
$925.92M
2022-03-01
2022-03-01
INGALLS KERRY
Chief Operating Officer
A - Grant
Employee Stock Option (Right to Buy)
72,568
$0.00
1
$925.92M
2022-03-01
2022-03-01
LEONHARDT HARRY
GC & Chief Compliance Officer
A - Grant
Employee Stock Option (Right to Buy)
72,568
$0.00
1
$925.92M
2022-03-01
2022-03-01
LEONHARDT HARRY
GC & Chief Compliance Officer
A - Grant
Common Stock
50,000
$0.00
1
$925.92M
2022-03-01
2022-03-01
MYLET JOHANNA
Chief Financial Officer
A - Grant
Employee Stock Option (Right to Buy)
72,568
$0.00
1
$925.92M
2022-03-01
2022-03-01
MYLET JOHANNA
Chief Financial Officer
A - Grant
Common Stock
50,000
$0.00
1
$925.92M
2022-03-01
2022-03-01
SPEAR MATTHEW
Chief Medical Officer
A - Grant
Employee Stock Option (Right to Buy)
72,568
$0.00
1
$925.92M
2022-03-01
2022-03-01
WARNER BRENT
President, Gene Therapy
A - Grant
Stock Option (Right to Buy)
431K
$0.00
1
$925.92M
2022-02-01
2022-02-01
GERGEN MARK
President and CEO
A - Grant
Stock Option (Right to Buy)
519K
$0.00
1
$925.92M
2022-02-01
2022-02-01
OSTERTAG ERIC
Executive Chairman
A - Grant
Employee Stock Option (Right to Buy)
130K
$0.00
2
$925.92M
2021-12-21
2021-12-22
MYLET JOHANNA
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-5,716
$0.00
2
$925.92M
2021-12-21
2021-12-22
MYLET JOHANNA
Chief Financial Officer
M - Exercise
Common Stock
5,716
$2.00
11,432
2
$925.92M
2021-12-06
2021-12-08
SPEAR MATTHEW
Chief Medical Officer
M - Exercise
Common Stock
10,000
$1.00
10,000
1
$925.92M
2021-12-06
2021-12-08
SPEAR MATTHEW
Chief Medical Officer
M - Exercise
Stock Option (Right to Buy)
-10,000
$0.00
1
$925.92M
2021-12-06
2021-12-07
MALIN LIFE SCIENCES HOLDINGS LTD
P - Purchase
COMMON STOCK
1,828
$7.00
12,796
1
$925.92M
2021-12-02
2021-12-02
MALIN LIFE SCIENCES HOLDINGS LTD
P - Purchase
COMMON STOCK
4,296
$7.00
30,072
1
$925.92M
2021-12-01
2021-12-02
MALIN LIFE SCIENCES HOLDINGS LTD
P - Purchase
COMMON STOCK
18,365
$7.00
129K
1
$925.92M
2021-11-30
2021-12-02
MALIN LIFE SCIENCES HOLDINGS LTD
P - Purchase
COMMON STOCK
28,592
$7.00
200K
1
$925.92M
2021-11-29
2021-11-29
MALIN LIFE SCIENCES HOLDINGS LTD
P - Purchase
COMMON STOCK
11,057
$7.00
77,399
1
$925.92M
2021-11-26
2021-11-29
MALIN LIFE SCIENCES HOLDINGS LTD
P - Purchase
COMMON STOCK
27,251
$7.00
191K
1
$925.92M
2021-11-24
2021-11-29
MALIN LIFE SCIENCES HOLDINGS LTD
P - Purchase
COMMON STOCK
1,054
$7.00
7,378
1
$925.92M
2021-11-23
2021-11-23
MALIN LIFE SCIENCES HOLDINGS LTD
P - Purchase
COMMON STOCK
14,625
$7.00
102K
1
$925.92M
2021-11-19
2021-11-23
MALIN LIFE SCIENCES HOLDINGS LTD
P - Purchase
COMMON STOCK
11,104
$7.00
77,728
1
$925.92M
2021-11-19
2021-11-22
OSTERTAG ERIC
Chief Executive Officer
M - Exercise
Employee Stock Option (Right to Buy)
-1,000
$0.00
1
$925.92M
2021-11-19
2021-11-22
OSTERTAG ERIC
Chief Executive Officer
M - Exercise
Common Stock
1,000
$9.00
9,000
1
$925.92M
2021-11-18
2021-11-18
MALIN LIFE SCIENCES HOLDINGS LTD
P - Purchase
COMMON STOCK
71,312
$7.00
499K
1
$925.92M
2021-11-17
2021-11-18
INGALLS KERRY
Chief Operating Officer
P - Purchase
Common Stock
2,000
$7.00
14,000
1
$925.92M
2021-11-17
2021-11-18
MALIN LIFE SCIENCES HOLDINGS LTD
P - Purchase
COMMON STOCK
280K
$7.00
1.96M
1
$925.92M
2021-11-16
2021-11-18
MALIN LIFE SCIENCES HOLDINGS LTD
P - Purchase
COMMON STOCK
27,680
$7.00
194K
1
$925.92M
2021-11-08
2021-11-10
OSTERTAG ERIC
Chief Executive Officer
S - Sale
Common Stock
-18,924
$7.00
-132K
2
$925.92M
2021-11-01
2021-11-02
MYLET JOHANNA
Chief Financial Officer
A - Grant
Employee Stock Option (Right to Buy)
65,000
$0.00
1
$925.92M
2021-10-11
2021-10-13
OSTERTAG ERIC
Chief Executive Officer
M - Exercise
Employee Stock Option (Right to Buy)
-18,525
$0.00
1
$925.92M
2021-10-11
2021-10-13
OSTERTAG ERIC
Chief Executive Officer
M - Exercise
Common Stock
18,525
$9.00
167K
1
$925.92M
2021-10-01
2021-10-05
OSTERTAG ERIC
Chief Executive Officer
S - Sale
Common Stock
-20,029
$7.00
-140K
2
$925.92M
2021-09-20
2021-09-22
OSTERTAG ERIC
Chief Executive Officer
S - Sale
Common Stock
-20,000
$8.00
-160K
1
$925.92M
2021-09-14
2021-09-15
OSTERTAG ERIC
Chief Executive Officer
S - Sale
Common Stock
-20,000
$8.00
-160K
1
$925.92M
2021-09-13
2021-09-15
OSTERTAG ERIC
Chief Executive Officer
M - Exercise
Employee Stock Option (Right to Buy)
-21,281
$0.00
2
$925.92M
2021-09-13
2021-09-15
OSTERTAG ERIC
Chief Executive Officer
M - Exercise
Common Stock
21,281
$8.00
170K
2
$925.92M
2021-09-09
2021-09-10
SPEAR MATTHEW
Chief Medical Officer
M - Exercise
Stock Option (Right to Buy)
-10,000
$0.00
1
$925.92M
2021-09-09
2021-09-10
SPEAR MATTHEW
Chief Medical Officer
M - Exercise
Common Stock
10,000
$1.00
10,000
1
$925.92M
2021-09-02
2021-09-03
OSTERTAG ERIC
Chief Executive Officer
S - Sale
Common Stock
-61,262
$8.00
-490K
2
$925.92M
2021-09-01
2021-09-03
OSTERTAG ERIC
Chief Executive Officer
S - Sale
Common Stock
-51,149
$8.00
-409K
2
$925.92M
2021-08-20
2021-08-24
SPEAR MATTHEW
Chief Medical Officer
S - Sale
Common Stock
-4,000
$9.00
-36,000
1
$925.92M
2021-08-20
2021-08-24
SPEAR MATTHEW
Chief Medical Officer
M - Exercise
Stock Option (Right to Buy)
-4,000
$0.00
1
$925.92M
2021-08-20
2021-08-24
SPEAR MATTHEW
Chief Medical Officer
M - Exercise
Common Stock
4,000
$1.00
4,000
1
$925.92M
2021-08-06
2021-08-10
OSTERTAG ERIC
Chief Executive Officer
M - Exercise
Employee Stock Option (Right to Buy)
-111K
$0.00
1
$925.92M
2021-08-06
2021-08-10
OSTERTAG ERIC
Chief Executive Officer
M - Exercise
Common Stock
111K
$9.00
1.00M
1
$925.92M
2021-08-03
2021-08-04
OSTERTAG ERIC
Chief Executive Officer
S - Sale
Common Stock
-19,936
$8.00
-159K
2
$925.92M
2021-08-02
2021-08-04
OSTERTAG ERIC
Chief Executive Officer
S - Sale
Common Stock
-13,737
$8.00
-110K
2
$925.92M
2021-07-28
2021-07-30
SPEAR MATTHEW
Chief Medical Officer
M - Exercise
Stock Option (Right to Buy)
-20,000
$0.00
1
$925.92M
2021-07-28
2021-07-30
SPEAR MATTHEW
Chief Medical Officer
M - Exercise
Common Stock
20,000
$1.00
20,000
1
$925.92M
2021-07-02
2021-07-06
OSTERTAG ERIC
Chief Executive Officer
S - Sale
Common Stock
-27,542
$9.00
-248K
4
$925.92M
2021-07-01
2021-07-06
OSTERTAG ERIC
Chief Executive Officer
S - Sale
Common Stock
-20,563
$10.00
-206K
2
$925.92M
2021-06-17
2021-06-21
SPEAR MATTHEW
Chief Medical Officer
M - Exercise
Stock Option (Right to Buy)
-5,000
$0.00
1
$925.92M
2021-06-17
2021-06-21
SPEAR MATTHEW
Chief Medical Officer
M - Exercise
Common Stock
5,000
$1.00
5,000
1
$925.92M
2021-06-11
2021-06-14
SPEAR MATTHEW
Chief Medical Officer
S - Sale
Common Stock
-4,000
$9.00
-36,000
1
$925.92M
2021-06-11
2021-06-14
SPEAR MATTHEW
Chief Medical Officer
M - Exercise
Stock Option (Right to Buy)
-4,000
$0.00
1
$925.92M
2021-06-11
2021-06-14
SPEAR MATTHEW
Chief Medical Officer
M - Exercise
Common Stock
4,000
$1.00
4,000
1
$925.92M
2021-06-02
2021-06-03
OSTERTAG ERIC
Chief Executive Officer
S - Sale
Common Stock
-40,722
$8.00
-326K
2
$925.92M
2021-06-01
2021-06-03
OSTERTAG ERIC
Chief Executive Officer
S - Sale
Common Stock
-41,194
$9.00
-371K
2
$925.92M
2021-05-04
2021-05-05
OSTERTAG ERIC
Chief Executive Officer
S - Sale
Common Stock
-35,986
$8.00
-288K
2
$925.92M
2021-05-03
2021-05-05
OSTERTAG ERIC
Chief Executive Officer
S - Sale
Common Stock
-18,326
$9.00
-165K
2
$925.92M
2021-04-23
2021-04-23
SPEAR MATTHEW
Chief Medical Officer
M - Exercise
Stock Option (Right to Buy)
-5,000
$0.00
1
$925.92M
2021-04-23
2021-04-23
SPEAR MATTHEW
Chief Medical Officer
M - Exercise
Common Stock
5,000
$1.00
5,000
1
$925.92M
2021-04-21
2021-04-23
SPEAR MATTHEW
Chief Medical Officer
S - Sale
Common Stock
-4,000
$8.00
-32,000
1
$925.92M
2021-04-21
2021-04-23
SPEAR MATTHEW
Chief Medical Officer
M - Exercise
Stock Option (Right to Buy)
-4,000
$0.00
1
$925.92M
2021-04-21
2021-04-23
SPEAR MATTHEW
Chief Medical Officer
M - Exercise
Common Stock
4,000
$1.00
4,000
1
$925.92M
2021-04-05
2021-04-05
OSTERTAG ERIC
Chief Executive Officer
S - Sale
Common Stock
-57,819
$10.00
-578K
4
$925.92M
2021-04-01
2021-04-05
OSTERTAG ERIC
Chief Executive Officer
S - Sale
Common Stock
-57,181
$10.00
-572K
2
$925.92M
2021-03-02
2021-03-03
OSTERTAG ERIC
Chief Executive Officer
S - Sale
Common Stock
-57,060
$12.00
-685K
2
$925.92M
2021-03-01
2021-03-03
OSTERTAG ERIC
Chief Executive Officer
S - Sale
Common Stock
-57,940
$12.00
-695K
4
$925.92M
2021-02-23
2021-02-25
OSTERTAG ERIC
Chief Executive Officer
M - Exercise
Employee Stock Option (Right to Buy)
-111K
$0.00
1
$925.92M
2021-02-23
2021-02-25
OSTERTAG ERIC
Chief Executive Officer
M - Exercise
Common Stock
111K
$1.00
111K
1
$925.92M
2021-02-16
2021-02-17
OSTERTAG ERIC
Chief Executive Officer
S - Sale
Common Stock
-133K
$10.00
-1.33M
1
$925.92M
2021-02-10
2021-02-12
OSTERTAG ERIC
Chief Executive Officer
S - Sale
Common Stock
-12,389
$10.00
-124K
1
$925.92M
2021-02-10
2021-02-12
OSTERTAG ERIC
Chief Executive Officer
M - Exercise
Employee Stock Option (Right to Buy)
-67,534
$0.00
1
$925.92M
2021-02-10
2021-02-12
OSTERTAG ERIC
Chief Executive Officer
M - Exercise
Common Stock
67,534
$1.00
67,534
1
$925.92M
2021-02-04
2021-02-05
GERGEN MARK
President and CBO
A - Grant
Employee Stock Option (Right to Buy)
342K
$0.00
1
$925.92M
2021-02-04
2021-02-05
INGALLS KERRY
Chief Operating Officer
A - Grant
Employee Stock Option (Right to Buy)
137K
$0.00
1
$925.92M
2021-02-04
2021-02-05
LEONHARDT HARRY
GC & Chief Compliance Officer
A - Grant
Employee Stock Option (Right to Buy)
137K
$0.00
1
$925.92M
2021-02-04
2021-02-05
MYLET JOHANNA
Senior Vice President, Finance
A - Grant
Employee Stock Option (Right to Buy)
82,000
$0.00
1
$925.92M
2021-02-04
2021-02-05
OSTERTAG ERIC
Chief Executive Officer
A - Grant
Employee Stock Option (Right to Buy)
889K
$0.00
1
$925.92M
2021-02-04
2021-02-05
SPEAR MATTHEW
Chief Medical Officer
A - Grant
Employee Stock Option (Right to Buy)
164K
$0.00
1
$925.92M
2021-01-21
2021-01-25
OSTERTAG ERIC
Chief Executive Officer
S - Sale
Common Stock
-4,462
$10.00
-44,620
1
$925.92M
2021-01-15
2021-01-19
MYLET JOHANNA
Senior Vice President, Finance
M - Exercise
Stock Option (Right to Buy)
-4,728
$0.00
2
$925.92M
2021-01-15
2021-01-19
MYLET JOHANNA
Senior Vice President, Finance
M - Exercise
Common Stock
4,728
$0.00
1
$925.92M
2021-01-15
2021-01-19
SPEAR MATTHEW
Chief Medical Officer
M - Exercise
Stock Option (Right to Buy)
-7,564
$0.00
1
$925.92M
2021-01-15
2021-01-19
SPEAR MATTHEW
Chief Medical Officer
M - Exercise
Common Stock
7,564
$1.00
7,564
1
$925.92M
2021-01-08
2021-01-11
SPEAR MATTHEW
Chief Medical Officer
M - Exercise
Common Stock
3,921
$1.00
3,921
1
$925.92M
2021-01-08
2021-01-11
SPEAR MATTHEW
Chief Medical Officer
M - Exercise
Stock Option (Right to Buy)
-3,921
$0.00
1
$925.92M
2020-07-14
2020-07-15
MALIN LIFE SCIENCES HOLDINGS LTD
C - Conversion
Series C Preferred Stock
-393K
1
$925.92M
2020-07-14
2020-07-15
MALIN LIFE SCIENCES HOLDINGS LTD
C - Conversion
Series A Preferred Stock
-8.75M
1
$925.92M
2020-07-14
2020-07-15
MALIN LIFE SCIENCES HOLDINGS LTD
C - Conversion
Series A-1 Preferred Stock
-1.46M
1
$925.92M
2020-07-14
2020-07-15
MALIN LIFE SCIENCES HOLDINGS LTD
C - Conversion
Series B Preferred Stock
-861K
1
$925.92M
2020-07-14
2020-07-15
OSTERTAG ERIC
Chief Executive Officer
C - Conversion
Series A Preferred Stock
-319K
1
$925.92M
2020-07-14
2020-07-15
OSTERTAG ERIC
Chief Executive Officer
C - Conversion
Series A-1 Preferred Stock
-437K
1
$925.92M
2020-07-09
2020-07-13
GERGEN MARK
President and CBO
A - Grant
Stock Option (Right to Buy)
75,000
$0.00
1
$925.92M
2020-07-09
2020-07-13
MYLET JOHANNA
Senior Vice President, Finance
A - Grant
Stock Option (Right to Buy)
35,000
$0.00
1
$925.92M